A buyout will mean that we forfeit the possibility that trofinetide can assist in areas of the autism spectrum apart from Rett Syndrome and Fragile X.
Ann: Investor presentation, 25 November 2016, page-13
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.24 |
Change
0.140(0.70%) |
Mkt cap ! $2.579B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.43 | $20.14 | $701.9K | 34.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 69 | $20.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.25 | 106 | 2 |
View Market Depth
| Last trade - 11.26am 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |